4801 - 4825 of 9148 Results
Title
Year
-
RESTRICTEDTitle: Exploring the neuroprotective potential of immunosuppressants in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107294End Page: 107294Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107294Citation Count: 2
- Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonism2013RESTRICTEDTitle: Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.02.016Citation Count: 0
-
OPENTitle: Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 201End Page: 209Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8978879Citation Count: 22
- Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains2018RESTRICTEDTitle: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brainsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 309Issue #:Start Page: 91End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.016Citation Count: 52
-
OPENTitle: Deep learning-derived arterial input function for dynamic brain PETJournal Name: NeuroImagePublisher: Elsevier BVVol: 324Issue #:Start Page: 121609End Page: 121609Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2025.121609Best OA location URL: https://doi.org/10.1016/j.neuroimage.2025.121609Citation Count: 2
- A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regions2024RESTRICTEDTitle: A biobank for Parkinson's disease and atypical parkinsonism in central Asian and Transcaucasian regionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 9Start Page: 859End Page: 860Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00313-2Citation Count: 4
-
OPENTitle: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease DementiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 4Start Page: 479End Page: 483Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13451Citation Count: 29
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 7Start Page: 1253End Page: 1263Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://doi.org/10.1177/1877718x251356503Citation Count: 2
-
OPENTitle: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 18Issue #: 8Start Page: 724End Page: 735Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133481Citation Count: 126
-
OPENTitle: Levodopa-Induced dyskinesia in Latin America: Prevalence and associated clinical factors in the LARGE-PD cohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 4Start Page: 723End Page: 735Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261431204Best OA location URL: https://doi.org/10.1177/1877718x261431204Citation Count: 0
-
OPENTitle: Addressing the Challenges of Clinical Research for Freezing of Gait in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 264End Page: 267Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28837Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8840955Citation Count: 27
- Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation Carriers2021OPENTitle: Comparison of Transcranial Sonography and [18F]‐Fluorodopa PET Imaging in GBA1 Mutation CarriersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 629End Page: 634Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8940604Citation Count: 8
- Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's Disease2021OPENTitle: Re‐Analysis of the STEADY‐PD II Trial—Evidence for Slowing the Progression of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 334End Page: 342Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28850Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8922308Citation Count: 42
-
OPENTitle: Peripheral Klotho and Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1274End Page: 1276Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28530Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9295462Citation Count: 9
-
OPENTitle: Mild Neurological Signs in FMR1 Premutation Women in an Unselected Community‐Based CohortJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2378End Page: 2386Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.28683Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28683Citation Count: 5
-
OPENTitle: A Multi‐center Genome‐wide Association Study of Cervical DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2795End Page: 2801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28732Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688173Citation Count: 9
-
OPENTitle: Age of Onset of Huntington's Disease in Carriers of Reduced Penetrance AllelesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2958End Page: 2961Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28789Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8688195Citation Count: 10
-
OPENTitle: Auditory and olfactory findings in patients with USH2A‐related retinal degeneration—Findings at baseline from the rate of progression in USH2A‐related retinal degeneration natural history study (RUSH2A)Journal Name: American Journal of Medical Genetics Part APublisher: WileyVol: 185Issue #: 12Start Page: 3717End Page: 3727Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ajmg.a.62437Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8717864Citation Count: 10
-
OPENTitle: The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degenerationJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 7Start Page: 3158End Page: 3170Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12966Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12966Citation Count: 30
-
OPENTitle: Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 45Issue #: 4Start Page: 632End Page: 640Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-019-0589-zBest OA location URL: https://www.nature.com/articles/s41386-019-0589-z.pdfCitation Count: 63
-
OPENTitle: Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 538End Page: 549Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25430Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25430Citation Count: 187
-
OPENTitle: Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disordersJournal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 28Issue #: 7Start Page: 1893End Page: 1901Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11136-019-02164-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7071345Citation Count: 27
-
OPENTitle: The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cellsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 11829End Page: 11829Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-47352-9Best OA location URL: https://www.nature.com/articles/s41598-019-47352-9.pdfCitation Count: 56
-
OPENTitle: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Journal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 1345End Page: 1358Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.049551Best OA location URL: http://doi.org/10.1124/mol.108.049551Citation Count: 186
-
OPENTitle: Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 5Start Page: 704End Page: 714Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25450Best OA location URL: https://escholarship.org/uc/item/5b88v0w3Citation Count: 160